Centrum Badań Klinicznych I Rejestrówsp. z o.o.
Research and experimental development in natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2012-03-22
Share capital
100,000.00 PLN
Registered address
ul. Wielicka 44/31, 30-552 Kraków, Poland
Electronic delivery address
AE:PL-28340-99784-GGASB-31
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 5 of 6 financial statements were filed late (the longest delay 986 days for 2020).
- 2025not filed
- 202406/10/2025
- 202327/06/2024
- 202227/06/2024
- 202127/06/2024
- 202027/06/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Revenue
This companyUSD 31.50kMedianUSD 152.85kAverageUSD 4.86m
Net profit
This companyUSD -25.20kMedianUSD -228.23AverageUSD 317.06k
Operating costs
This companyUSD 56.69kMedianUSD 187.91kAverageUSD 4.67m
Assets
This companyUSD 21.22kMedianUSD 278.35kAverageUSD 8.47m
Industry
Authorized Representatives
Joanna Zyguła – Management Board Member
Paweł Piotr Musiał – Management Board Member
Rafał Sadowski – President of the Management Board
Manner of representation
The company is represented by each member of the management board acting independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 1,000 | $27,012.43 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2018-03-01.
71 1050 1445 1000 0090 8187 4415
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| ArdigenS.A. | $12,513,309.89 | ardigen.com | ||
| IntodnaS.A. | $2,286,118.76 | intodna.com | ||
| Real ResearchS.A. | $565,296.66 | real-research.com | ||
| VET Cell Techsp. z o.o. | $483,439.81 | vetcelltech.com | ||
| Dicellasp. z o.o. | $206,073.49 | dicella.com | ||
| Space Tech Gatewaysp. z o.o. | $48,583.75 | spacetechgateway.com | ||
| Advanced Diagnostic Equipmentsp. z o.o. | $43,171.56 | adediabetics.pl | ||
| Micropurasp. z o.o. | $12,556.50 | micropura.eu | ||
| Alsitechsp. z o.o. | $106.21 | alsitech.pl | ||
| Krakowska Szkoła Browarniczasp. z o.o. | – | ksb.edu.pl |
Change history
| Date | Event | |
|---|---|---|
| 2022-09-01 | Name change (Centrum Badawczo-Rozwojowe → Centrum Badań Klinicznych I Rejestrów) | |
| 2022-09-01 | PKD change (Removed: 9 codes; Added: 9 codes) | |
| 2022-01-01 | Business resumed | |
| 2020-01-01 | Business suspended | |
| 2019-11-04 | Name change (Centrum Badań Klinicznych I Rejestrów → Centrum Badawczo-Rozwojowe) |
FAQ
The main business activity of Centrum Badań Klinicznych i Rejestrów focuses on research and experimental development in natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on March 22, 2012.
The headquarters is located at: ul. Wielicka 44, 30-552 Kraków.
The share capital of the company is PLN 100,000 (approx. $27,012).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $31,496 in 2024, which is a decrease of 44.9% compared to 2023.
No, in 2024 the company was not profitable, reporting a net loss of $25,195. For comparison, in 2023 the loss was $29,344, meaning the company reduced its loss by 18.5%.
Last updated: 2026-10-07